Par Pharmaceutical Companies Inc (PRX) financial statements (2021 and earlier)

Company profile

Business Address ONE RAM RIDGE ROAD
CHESTNUT RIDGE, NY 10977
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments244134
Cash and cash equivalents244130
Short-term investments 4
Receivables159143
Inventory, net of allowances, customer advances and progress billings155117
Inventory155117
Income taxes receivable1
Other undisclosed current assets9570
Total current assets:653466
Noncurrent Assets
Property, plant and equipment217127
Intangible assets, net (including goodwill)2,0531,942
Goodwill1,012850
Intangible assets, net (excluding goodwill)1,0411,093
Other noncurrent assets8496
Total noncurrent assets:2,3542,166
TOTAL ASSETS:3,0072,631
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16767
Accounts payable8031
Accrued liabilities4815
Employee-related liabilities3221
Interest and dividends payable8 
Debt1521
Estimated litigation liability 41
Other undisclosed current liabilities96129
Total current liabilities:278259
Noncurrent Liabilities
Long-term debt and lease obligation1,9041,516
Long-term debt, excluding current maturities1,9041,516
Liabilities, other than long-term debt247289
Deferred tax liabilities, net247289
Other undisclosed noncurrent liabilities(2,134)(1,785)
Total noncurrent liabilities:1720
Total liabilities:295279
Stockholders' equity
Stockholders' equity attributable to parent561547
Additional paid in capital809687
Accumulated other comprehensive loss(4)(1)
Accumulated deficit(244)(138)
Total stockholders' equity:561547
Other undisclosed liabilities and equity2,1511,805
TOTAL LIABILITIES AND EQUITY:3,0072,631

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
Other undisclosed net loss attributable to parent (106)
Net loss available to common stockholders, diluted: (106)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: